An important avenue of investigation in this regard, and potentially the biggest caveat in ABCA7 research to date, is the expression of (different isoforms of) ABCA7. AD-associated markers in ABCA7, as well as in vitro and in vivo experiments, point towards a decrease of ABCA7 as the main pathological mechanism. Here, ABCA7 is linked to Alzheimer disease.